New Delhi: The Drugs Controller General of India (DCGI) has allowed Mumbai-based Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country, Dr VK Paul, Member (Health), NITI Aayog said on Tuesday.
Paul said at a media briefing that an application was received from Moderna through his Indian partner Cipla, following which Moderna’s COVID-19 vaccine has been given “emergency use authorization restricted by the drug regulator”.
Read also | COVID-19 vaccine: No trial needed for single-dose Janssen in India, says Johnson & Johnson
“This new permission for restricted emergency use potentially opens up a clear possibility of this vaccine being imported into India in the near future,” PTI quoted Dr Paul as saying.
NITI Aayog Member (Health) informed that there are four vaccines with such license – Covishield, Covaxin, Sputnik and Modern.
Dr Paul further added, “We are also continuing our efforts to invite and place other internationally developed vaccines, particularly in Pfizer and J&K”.
“Those processes are on. We are also looking at increasing production of vaccines that are available to be manufactured in our country.
Earlier on June 27, Moderna informed India’s drug regulator that the US government has agreed to donate a certain number of doses of its COVID-19 vaccine through COVAX for use to India and the Central Drugs. Approval has been sought from Standard Control Organization (CDSCO). .
On Monday, American pharma company Cipla had requested the drug regulator for import and marketing authorization for these jabs.
Read also | Full immunization against Kovid-19 likely by December – Know why?
DCGI had earlier on June 1 decided to waive off testing of batches for foreign-made vaccines in CDLs, which have been approved by international drug regulators such as the US FDA, UK’s MHRA or, to expedite the rollout of vaccines. . WHO.
This came after the Center had earlier in April issued detailed guidelines and approved foreign-made COVID-19 pandemics by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), Drugs and Health Products Regulatory Agency (MHRA). Access to vaccines was made increasingly easier. ) UK, Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and WHO’s emergency use list in India.
See below health equipment-
Calculate your body mass index (BMI)
.